TOMZ stock is currently trading at $0.9542, down 3.15% in regular market trading on January 31, 2025. Despite a recent return to profitability and strong Q2 2024 results, including a 170% revenue increase, the stock remains under pressure due to its small market cap and high volatility. A bullish view would target a recovery above $1.00, supported by its regained Nasdaq compliance and growth initiatives in healthcare and food sectors.